{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:53:57Z","timestamp":1777859637318,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T00:00:00Z","timestamp":1509840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations are used to estimate kidney function. However, utility has been questioned in the obese population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate differences in estimates of kidney function in obese patients and implications for drug dosing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This was a retrospective study of adult inpatients with a body mass index \u226530 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and stable kidney function. Patients were categorized based on creatinine clearance (CrCl): group 1\u2014CrCl \u2265 60 mL\/min and group 2\u2014CrCl 15 to 59 mL\/min. Mean estimates of kidney function and recommended doses of 8 renally eliminated medications were compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>For the 166 patients included, mean estimates using CG, MDRD, and CKD-EPI for group 1 were 87 (23) mL\/min, 91 (21) mL\/min, and 96 (23) mL\/min, respectively. Group 2 estimates were 42 (13) mL\/min, 51 (15) mL\/min, and 51 (16) mL\/min, respectively. MDRD and CKD-EPI estimates were significantly higher than CG in 125 (75%) and 140 (84%) patients, respectively. Dose discrepancies were most often due to higher dose recommendations using MDRD or CKD-EPI compared to CG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Careful consideration of the method used to estimate kidney function, the method used for developing dosing recommendations, and the risk\u2013benefit profile is warranted when designing drug regimens in obese individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0897190017737895","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T22:09:51Z","timestamp":1509919791000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Disagreement in Estimates of Kidney Function for Drug Dosing in Obese Inpatients"],"prefix":"10.1177","volume":"32","author":[{"given":"Emily A.","family":"Higdon","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Kentucky HealthCare, Lexington, KY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Kimmons","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Methodist University Hospital, Memphis, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Benjamin T.","family":"Duhart","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The University of Tennessee, Memphis, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna Q.","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The University of Tennessee, Memphis, TN, USA"},{"name":"Department of Medicine (Nephrology), The University of Tennessee, Memphis, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,11,5]]},"reference":[{"key":"bibr1-0897190017737895","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S61795"},{"key":"bibr2-0897190017737895","first-page":"271","volume-title":"Pharmacotherapy: A Pathophysiologic Approach","author":"Dowling TC","year":"2014","edition":"8"},{"key":"bibr3-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"bibr4-0897190017737895","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"bibr5-0897190017737895","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"bibr6-0897190017737895","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"bibr7-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.12.006"},{"issue":"1","key":"bibr8-0897190017737895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int"},{"key":"bibr9-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2010.05.010"},{"key":"bibr10-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328348c11f"},{"key":"bibr11-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.187"},{"key":"bibr12-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft329"},{"key":"bibr13-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070549"},{"key":"bibr14-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12817"},{"key":"bibr15-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00174-11"},{"issue":"11","key":"bibr16-0897190017737895","first-page":"650","volume":"8","author":"Devine BJ","year":"1974","journal-title":"Drug Intell Clin Pharm"},{"key":"bibr17-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1007\/BF00542215"},{"key":"bibr18-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2012.01098.x"},{"key":"bibr19-0897190017737895","unstructured":"Dabigatran [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2014."},{"key":"bibr20-0897190017737895","unstructured":"Daptomycin [package insert]. Lexington, MA: Cubist Pharmaceuticals, Inc; 2013."},{"key":"bibr21-0897190017737895","unstructured":"Enoxaparin [package insert]. Bridgewater, NJ: Sanofi-aventis, LLC; 2009."},{"key":"bibr22-0897190017737895","unstructured":"Gabapentin [package insert]. New York, NY: Pfizer, Inc; 2009."},{"key":"bibr23-0897190017737895","unstructured":"Levetiracetam [package insert]. Smyrna, GA: UCB, Inc; 2009."},{"key":"bibr24-0897190017737895","unstructured":"Levetiracetam XR [package insert]. Smyrna, GA: UCB, Inc; 2014."},{"key":"bibr25-0897190017737895","unstructured":"Meropenem [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals; 2013."},{"key":"bibr26-0897190017737895","unstructured":"Piperacillin and Tazobactam [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals, Inc; 2012."},{"key":"bibr27-0897190017737895","unstructured":"Rivaroxaban [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2014."},{"key":"bibr28-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000211805.89440.3d"},{"key":"bibr29-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2007.01.008"},{"key":"bibr30-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.07.015"},{"key":"bibr31-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000065"},{"key":"bibr32-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1186\/cc13899"},{"key":"bibr33-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12501"},{"key":"bibr34-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158677"},{"key":"bibr35-0897190017737895","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.242"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190017737895","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190017737895","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190017737895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:34:44Z","timestamp":1777509284000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190017737895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1177\/0897190017737895"],"URL":"https:\/\/doi.org\/10.1177\/0897190017737895","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,5]]}}}